Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro

Planta Medica

Volumn 75, Issue 8, 2009, Pages 797-802

  Lai, Li ^a   Hao, Haiping ^a   Liu, Yitong ^a   Zheng, Chaonan ^a   Wang, Qiong ^a   Wang, Guangji ^a   Chen, Xijin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

20(S) ginsenoside Rh1; Araliaceae; Metabolism; Panax ginseng C. A. Meyer; Pharmacokinetics

Indexed keywords

CYTOCHROME P450; GINSENOSIDE; GINSENOSIDE RH 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; ENZYME DEGRADATION; GLYCOSYLATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT;

ANIMALS; BILE; BIOLOGICAL AVAILABILITY; CYTOCHROME P-450 ENZYME SYSTEM; GASTRIC ACID; GINSENOSIDES; INTESTINES; LIVER; MALE; METABOLIC NETWORKS AND PATHWAYS; PANAX; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

ARALIACEAE; PANAX GINSENG; RATTUS;

EID: 67249119760     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185400     Document Type: Article

References (19)

1. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001; 16 (Suppl.): S28-S37
2. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004; 133: 113-120
3. Wang Y,Wang BX, Liu TH,Minami M, Nagata T, Ikejima T. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1. Acta Pharmacol Sin 2000; 21: 792-796
4. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004; 95: 153-157 (Pubitemid 38899683)
5. Wang Y, Liu TH, Wang W, Wang BX. Research on the transformation of ginsenoside Rg1 by intestinal flora. China J Chin Mater Med 2001; 26: 188-190
6. Chang YW, Yao HT, Chien DS, Yeh TK. High-performance liquid chromatography-electrospray mass spectrometry for the simultaneous determination of multiple active components in Sheng-Mai San, a prescription of traditional Chinese medicine. Phytochem Anal 2008; 19: 258-265
7. Zhu D, Li Z, Yan Y, Zhu J. A research on chemical dynamic changes and drug efficacy of shengmaisan compound prescription: chemical researches on shengmaisan prescription (II). China J Chin Mater Med 1998; 23: 291-293, 319-320
8. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003; 31: 1065-1071 (Pubitemid 36975678)
9. Cai ZW, Qian TX, Wong RNS, Jiang ZH. Liquid chromatography-electrospray ionization mass spectrometry for metabolism and pharmacokinetic studies of ginsenoside Rg3. Anal Chim Acta 2003; 492: 283-293 (Pubitemid 37101408)
10. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S, Tanaka O. Degradation of ginseng saponins under mild acidic conditions. Planta Med 1982; 44: 146-149
11. Zhang X, Song F, Cui M, Liu Z, Liu S. Investigation of the hydrolysis of ginsenosides by high performance liquid chromatography-electrospray ionization mass spectrometry. Planta Med 2007; 73: 1225-1229 (Pubitemid 47572363)
12. Qian T, Cai Z, Wong RN, Mak NK, Jiang ZH. In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 816: 223-232
13. Hao H,Wang G, Cui N, Li J, Xie L, Ding Z. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr Drug Metab 2007; 8: 137-149 (Pubitemid 46218680)
14. Von Bahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H. Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 1980; 27: 711-725 (Pubitemid 10072956)
15. Sun J,Wang G, Xie HT, Li H, Pan GY, Tucker I. Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction. J Pharm Biomed Anal 2005; 38: 126-132 (Pubitemid 40725098)
16. Li X, Sun JG, Wang GJ, Hao HP, Liang Y, Zheng Y, Yan B, Sheng L. Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ESI/MS: platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine. Biomed Chromatogr 2007; 21: 735-746 (Pubitemid 47073124)
17. Li X, Wang GJ, Sun JG, Hao HP, Xiong Y, Yan B, Zheng Y, Sheng L. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. Biol Pharm Bull 2007; 30: 847-851 (Pubitemid 46708624)
18. Kasai R, Hara K, Dokan R, Suzuki N, Mizutare T, Yoshihara S, Yamasaki K. Major metabolites of ginseng sapogenins formed by rat liver microsomes. Chem Pharm Bull (Tokyo) 2000; 48: 1226-1227 (Pubitemid 30660288)
19. Hasegawa H, Suzuki R, Nagaoka T, Tezuka Y, Kadota S, Saiki I. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol Pharm Bull 2002; 25: 861-866 (Pubitemid 40022113)